Daxor Corporation (DXR)
NCM · Healthcare · Medical Instruments & Supplies
$9.26
-5.12%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$54.1M
Shares Outstanding
5.8M
Exchange
NCM
Currency
USD
About Daxor Corporation
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 6.3M | 1.3M | 2.1M | 10.3M |
| Net Income | 5.2M | 281K | 536K | 9.2M |
| Diluted EPS | $0.87 | $0.14 | $-0.09 | $1.64 |